CARLE PLACE, N.Y., July 20, 2015 /PRNewswire/ -- Compassionate Care Center of New York™ (CCCNY™), also known as Tikun Olam in New York, a leading privately-held New York-based biopharmaceutical company applying to become one of five Registered Organizations operating under New York State's Medical Marijuana Program, has announced the formation of a charitable program that will follow the guidelines set forth by New York's Medicaid expansion under ObamaCare. This program, subject to its approval by the Commissioner of Health, will direct a portion of CCCNY's proceeds to pay for out-of-pocket expenses of qualifying Medical Marijuana patients living within 139% of the Federal Poverty Level ("FPL"). This program will also offer cost-sharing subsidies, on a sliding scale, to patients with incomes ranging between 139%-400% of the FPL. For more information, please write to email@example.com.
"Currently, health insurance companies do not cover the cost of medical cannabis, which is why a charitable program such as this is so essential until insurance companies and the federal government decide to step up," said CCCNY Board Member, Reverend Jacques DeGraff. "Registered Organizations are not permitted to give away free or discounted product to lower income families, and there is currently no state program to account for indigent care, so we at CCCNY take it as our duty to make sure our life-saving medications are available to all New Yorkers in need."
To ensure that CCCNY is the first Registered Organization in New York State to have pharmaceutical-grade products available to qualifying patients, it has leased a currently operating 10 acre heated glass indoor greenhouse and manufacturing facility in Newark, NY, and will have its exclusively-licensed high CBD strains Haleigh's Hope™, Avidekel®, Rafael® and Midnight® in the ground by August. For more information about CCCNY's cultivation facility, please visit www.newarkgreenhouse.com.
Compassionate Care Center of New York™ (CCCNY™) is a leading privately held New York-based biopharmaceutical company, which has exclusively partnered in New York State with Tikun Olam® of Israel, MedReleaf™ of Canada, and The Flowering H.O.P.E. Foundation™ of Colorado. Along with these partnerships come exclusive perpetual licenses in New York State to all of Tikun Olam's, MedReleaf's and The Flowering Hope Foundation's proprietary genetics, expertise, technology, cultivation techniques, patient databases and talent, including Tikun Olam's 10,000 patient treatment database and its clinically tested and peer-reviewed medical cannabis strains, Avidekel®, Midnight® and Erez®. Through its partnership with the Flowering Hope Foundation, CCCNY also has an exclusive perpetual license in New York State to Haleigh's Hope™, one of two nationally recognized brands of high CBD medical cannabis oil used to treat pediatric epilepsy, and the first medical-grade CBD oil available in the U.S. For more information please visit www.cccofny.com.
Tikun Olam Ltd.
Tikun Olam® Ltd. is the first, largest and foremost supplier of medical Cannabis in Israel and is one of leading medical cannabis companies in the world. Founded in 2005, Tikun Olam has set the global standard for legal medical cannabis research, production and sales. It is the only large-scale industrial producer of medical cannabis in the State of Israel, supplying one third of qualifying Israeli patients with pharmaceutical-grade products. Tikun Olam has the most extensive patient experience treatment database in the field of medical cannabis with over 10,000 patients being monitored for nearly a decade and the data for the treatment of each patient's ailments recorded along with the efficacy of the different strain variations and dosages administered. It is the only private company to have its proprietary medical strains of specifically-bred cannabis clinically tested on humans and referenced by name in peer-reviewed published articles reporting on the successful trials.
Tikun Olam continues to dedicate a lot of time and resources into examining the efficiency and safety of its products: through constant follow-up with patients, laboratory studies, both in-vitro and in-vivo, retrospective studies, surveys and clinical interventional research. The company currently has over 20 on-going clinical trials in Israel. For more information please visit www.tikunolam.com.
MedReleaf™ is a leading privately held federally-licensed producer and distributor of medical-grade cannabis operating under a license from Health Canada. The company operates a 55,000 square foot state-of-the-art facility in Markham, Ontario, and is currently one of the largest suppliers in the Canadian market. Its leadership team consists of highly skilled and expert professionals have extensive backgrounds in health care management, molecular plant genetics, biotechnology, horticulture, clinical laboratory management and operations. MedReleaf is dedicated to being a leading research and development driven producer of world-class cannabis grown to medical grade standards and to offering the finest range of consistent, premium cannabis products, using superior genetics sourced from around the world. For more information please visit www.medreleaf.com.
The Flowering H.O.P.E. Foundation
The Flowering H.O.P.E. Foundation is a Colorado non-profit foundation, which owns the nationally recognized strain of high CBD medical cannabis, Haleigh's Hope™, used to treat pediatric epilepsy all over the U.S. It was the first medical-grade CBD oil available in the U.S. in 2009, and is currently sold by Rifle Mountain Dispensary™ in Colorado and Curaleaf™ in Connecticut. The Foundation's goal is to provide safe access to life changing medication to those that suffer from multiple ailments, including but not limited to, Cancer, Crohns, Epilepsy, and MS. It creates opportunities for patients to receive a better quality of life, making it possible for parents and caregivers to have some piece of mind that their loved ones get the best chance at a successful future. The Foundation also strives to spread healthcare education to communities far and wide. For more information, please visit www.floweringhope.co
SOURCE Compassionate Care Center of New York